Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild to Moderate COVID-19: The SCORPIO-SR Randomized Clinical Trial

Treatment options for COVID-19 are warranted irrespective of the presence of risk factors for severe disease. To assess the efficacy and safety of ensitrelvir in patients with mild to moderate COVID-19. This phase 3 part of a phase 2/3, double-blind, placebo-controlled randomized clinical trial was...

Ausführliche Beschreibung